Medicinal plants’ use among patients with dyslipidemia: an Iranian cross-sectional survey

Mohammad Hashem Hashempur 1 , 2 , Seyed Hamdollah Mosavat 3 , 4 , Mojtaba Heydari 3 , 5  and Mesbah Shams 6
  • 1 Department of Persian Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran (Islamic Republic of)
  • 2 Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  • 3 Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • 4 Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • 5 Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • 6 Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
Mohammad Hashem Hashempur
  • Department of Persian Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran (Islamic Republic of)
  • Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  • Search for other articles:
  • degruyter.comGoogle Scholar
, Seyed Hamdollah Mosavat
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Research Center for Psychiatry and Behavior Science, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Search for other articles:
  • degruyter.comGoogle Scholar
, Mojtaba Heydari
  • Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Search for other articles:
  • degruyter.comGoogle Scholar
and Mesbah Shams
  • Corresponding author
  • Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (Islamic Republic of)
  • Email
  • Search for other articles:
  • degruyter.comGoogle Scholar

Abstract

Background

Despite growing demand for medicinal plants, there is little data about their use by patients with dyslipidemia. We aimed to determine the prevalence, pattern, and associated factors for the use of medicinal plants among patients with dyslipidemia.

Methods

A 17-item semi-structured questionnaire was filled out by 195 patients with dyslipidemia in a cross-sectional study carried out in two academic endocrinology clinics in Shiraz, Iran. The questionnaire comprised of three main domains of demographic data (6 questions), clinical data (2 of them), and data related to the use of medicinal plants (totally 9 questions).

Results

A total of 77.4% of patients took medicinal plants. The most common medicinal herbs used by dyslipidemic patients were Zataria multiflora, Cinnamomum zeylanicum, and Zingiber officinale. Duration of dyslipidemia was significantly longer in herbal users than non-herbal users (p=0.04). Patients believing that concomitant use of conventional drugs and herbal preparations had synergic positive effects in addition to those persuaded that herbal preparations possessed less side effects, were significantly more likely to use medicinal plants (p=0.008 and 0.005, respectively). Additionally, most of the medicinal herb users (87.4%) changed neither the pattern nor the dosage of their medications all during herbal preparations use.

Conclusions

This study demonstrated a high prevalence of medicinal plants’ use among patients with dyslipidemia, which was associated with the duration of dyslipidemia, patients’ viewpoints about herbal preparations’ synergic positive effects, and their fewer side effects.

  • [1]

    de Sereday MS, Gonzalez C, Giorgini D, De Loredo L, Braguinsky J, Cobenas C, et al. Prevalence of diabetes, obesity, hypertension and dyslipidemia in the central area of Argentina. Diabetes Metab 2004;30:335–9.

    • Crossref
    • PubMed
    • Export Citation
  • [2]

    Ruixing Y, Fengping H, Shangling P, Dezhai Y, Weixiong L, Tangwei L, et al. Prevalence of dyslipidemia and its risk factors for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. J Investig Med 2006;54:191–200.

    • Crossref
    • Export Citation
  • [3]

    Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med 2014;5:373–93.

    • PubMed
    • Export Citation
  • [4]

    Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia prevalence in Iranian adult men: the impact of population-based screening on the detection of undiagnosed patients. World J Mens Health 2015;33:167–73.

    • Crossref
    • PubMed
    • Export Citation
  • [5]

    Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, et al. Prevalence of obesity, type II diabetes mellitus, dyslipidemia, and hypertension in the United States: findings from the GE centricity electronic medical record database. Popul Health Manag 2010;13:151–61.

    • Crossref
    • PubMed
    • Export Citation
  • [6]

    Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 2007;7:32.

    • Crossref
    • PubMed
    • Export Citation
  • [7]

    Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. Trends in publication of evidence-based traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord 2013;12:49.

    • Crossref
    • PubMed
    • Export Citation
  • [8]

    World Health Organization. WHO traditional medicine strategy 2002–2005. Geneva: World Health Organization, 2002.

  • [9]

    Wilkinson JM, Stevens MJ. Use of complementary and alternative medical therapies (CAM) by patients attending a regional comprehensive cancer care centre. J Complement Integr Med 2014;11:139–45.

    • PubMed
    • Export Citation
  • [10]

    Jabbari M, Daneshfard B, Emtiazy M, Khiveh A, Hashempur MH. Biological effects and clinical applications of Dwarf Elder (Sambucus ebulus L): a review. J Evid Based Complementary Altern Med 2017;22:996–1001.

    • Crossref
    • Export Citation
  • [11]

    Lee G, Charn T, Chew Z, Ng T. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 2004;21:654–60.

    • Crossref
    • PubMed
    • Export Citation
  • [12]

    Hasan SS, Ahmed SI, Bukhari NI, Loon WC. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 2009;15:152–7.

    • Crossref
    • PubMed
    • Export Citation
  • [13]

    Wazaify M, Alawwa I, Yasein N, Al-Saleh A, Afifi FU. Complementary and alternative medicine (CAM) use among Jordanian patients with chronic diseases. Complement Ther Clin Pract 2013;19:153–7.

    • Crossref
    • PubMed
    • Export Citation
  • [14]

    Bregum F. The present status of medicinal plants in Bangladesh. Iran J Pharm Res 2010;3:34.

  • [15]

    Tangkiatkumjai M, Boardman H, Walker DM. Herbal and dietary supplement use in Bangkok: a survey. J Complement Integr Med 2014;11:203–11.

    • PubMed
    • Export Citation
  • [16]

    Akrami R, Hashempur MH, Tavakoli A, Nimrouzi M, Sayadi M, Roodaki M, et al. Effects of Fumaria parviflora L on uremic pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Jundishapur J Nat Pharm Prod 2017;12:e39744.

  • [17]

    Spinks J, Johnston D, Hollingsworth B. Complementary and alternative medicine (CAM) use and quality of life in people with type 2 diabetes and/or cardiovascular disease. Complement Ther Med 2014;22:107–15.

    • Crossref
    • PubMed
    • Export Citation
  • [18]

    Dehghan M, Mokhtarabadi S, Heidari FG. Complementary and alternative medicine usage and its determinant factors among Iranian infertile couples. J Complement Integr Med 2018;15. DOI:

    • Crossref
    • PubMed
    • Export Citation
  • [19]

    Organisation mondiale de la santé. WHO global atlas of traditional, complementary and alternative medicine. Geneva: World Health Organization, 2005.

  • [20]

    Cheraghali AM Herbal medicine in the Islamic Republic of Iran. World Health Organization. 2016;4: 14. Available at: http://apps.who.int/medicinedocs/en/d/Js4923e/3.5.html#Js4923e.3.5

  • [21]

    Hooper D, Field H, Dahlgren BE Useful plants and drugs of Iran and Iraq. Field Museum of Natural History. 1937.

  • [22]

    Nowbandegani AS, Kiumarcy S, Rahmani F, Dokouhaki M, Khademian S, Zarshenas MM, et al. Ethnopharmacological knowledge of shiraz and Fasa in Fars region of Iran for diabetes mellitus. J Ethnopharmacol 2015;172:281–7.

    • Crossref
    • PubMed
    • Export Citation
  • [23]

    Hassanzade Ajiri D Herbal life: traditional medicine gets a modern twist in Iran. 2016;4: 14. Available at: http://www.theguardian.com/world/iran-blog/2016/apr/11/iran-traditional-medicine-herbs-regulation-tehranbureau

  • [24]

    Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med 2015;13:319–25.

    • Crossref
    • PubMed
    • Export Citation
  • [25]

    Kashani L, Hassanzadeh E, Mirzabeighi A, Akhondzadeh S. Knowledge, attitude and practice of herbal remedies in a group of infertile couples. Acta Med Iran 2013;51:189–94.

  • [26]

    Fahimi F, Hrgovic I, El-Safadi S, Munstedt K. Complementary and alternative medicine in obstetrics: a survey from Iran. Arch Gynecol Obstet 2011;284:361–4.

    • Crossref
    • PubMed
    • Export Citation
  • [27]

    Sattari M, Dilmaghanizadeh M, Hamishehkar H, Mashayekhi SO. Self-reported use and attitudes regarding herbal medicine safety during pregnancy in Iran. Jundishapur J Nat Pharm Prod 2012;7:45.

    • Crossref
    • PubMed
    • Export Citation
  • [28]

    Tabatabaee M. Use of herbal medicine among pregnant women referring to Valiasr Hospital in Kazeroon, Fars, South of Iran. J Med Plants 2011;1:96–108.

  • [29]

    Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 2005;13:339–42.

    • Crossref
    • PubMed
    • Export Citation
  • [30]

    Montazeri A, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care 2007;16:144–9.

    • Crossref
    • Export Citation
  • [31]

    Harirchian MH, Sahraian MA, Hosseinkhani A, Amirzargar N. Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis. Iran J Neurol 2014;13:13.

    • PubMed
    • Export Citation
  • [32]

    Yekta Z, Zamani A, Mehdizade M, Farajzadegan Z. Pattern of complementary and alternative medicine use in urban population. J Res Health Sci 2007;7:24–31.

    • PubMed
    • Export Citation
  • [33]

    Chang H, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs 2007;58:307–19.

    • Crossref
    • PubMed
    • Export Citation
  • [34]

    Sina I 1037, Al-Qanoon Fit-Tib (Principles in medicine). Reprinted in 1970 from Bulaq. Lebanon: edition Sader Publishing House Beirut.

  • [35]

    Khorasani MA. Makhzan al Advieh. Tehran: Bavardaran Press Research institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, 2001.

  • [36]

    Khoshvaghti A, Nazifi S, Derakhshaniyan S, Akbarpour B. The effects of Zataria multiflora hydroalcoholic extract on some liver enzymes, cholesterol, triglyceride, HDL-cholesterol, LDL cholesterol, albumin and total protein in rat. J Basic Appl Sci 2012;8:217–22.

  • [37]

    Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med 2014;2014:642942.

  • [38]

    Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215–8.

    • Crossref
    • PubMed
    • Export Citation
  • [39]

    Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels. A double blind controlled clinical trial. Saudi Med J 2008;29:1280–4.

  • [40]

    Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 2014;65:515–20.

    • Crossref
    • PubMed
    • Export Citation
  • [41]

    Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Green tea consumption and serum lipid profiles: a cross-sectional study in northern Kyushu, Japan. Prev Med 1992;21:526–31.

    • Crossref
    • PubMed
    • Export Citation
  • [42]

    Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 2007;18:179–83.

    • Crossref
    • PubMed
    • Export Citation
  • [43]

    Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 2007;16:422–6.

    • PubMed
    • Export Citation
  • [44]

    Kassaian N, Azadbakht L, Forghani B, Amini M. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res 2009;79:34–9.

    • Crossref
    • PubMed
    • Export Citation
  • [45]

    Rafraf M, Zemestani M, Asghari-Jafarabadi M. Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes. J Endocrinol Invest 2015;38:163–70.

    • Crossref
    • PubMed
    • Export Citation
  • [46]

    Guo YT, Lan W. Effect of uigur traditional herb matricaria chamomile extract on serum lipid of experimental hyperl ipidmia rats. J Shandong Polytech Univ (NatSci Ed) 2013;2:009.

  • [47]

    Solati M, Farshidfar G, Vakil MK, Saberi P, Kamalinajad M, Solati N. Effect of administration of Teucrium polium on blood glucose and lipid levels in streptozotocin-induced diabetic rats. Physiol Pharmacol. 2013;16:423–34

  • [48]

    Ayoubi A, Omidi A, Valizade R, Mousaei A. Effect of hydroalcoholic extract of Aloe vera and Teucrium on serum glucose and lipid profile in streptozotocin diabetic male rats. J Birjand Univ Med Sci 2013;20:144–52.

  • [49]

    Hosseini S, Jamshidi L, Mehrzadi S, Mohammad K, Najmizadeh AR, Alimoradi H, et al. Effects of juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. J Ethnopharmacol 2014;152:451–6.

    • Crossref
    • PubMed
    • Export Citation
  • [50]

    Kwak JS, Kwon O. The effect of walnut (Juglans regia L.) intake on improvement of blood lipid levels and vascular health: a meta-analysis. J Nutr Health 2014;47:236–46.

    • Crossref
    • Export Citation
  • [51]

    Hajhashemi V, Abbasi N. Hypolipidemic activity of Anethum graveolens in rats. Phytother Res 2008;22:372–5.

    • Crossref
    • PubMed
    • Export Citation
  • [52]

    Yazdanparast R, Alavi M. Antihyperlipidaemic and antihypercholesterolaemic effects of Anethum graveolens leaves after the removal of furocoumarins. Cytobios 2001;105:185–91.

    • PubMed
    • Export Citation
  • [53]

    Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis 2007;6:5.

    • Crossref
    • PubMed
    • Export Citation
  • [54]

    Daher CF, Baroody KG, Baroody GM. Effect of Urtica dioica extract intake upon blood lipid profile in the rats. Fitoterapia 2006;77:183–8.

    • Crossref
    • PubMed
    • Export Citation
Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

The Journal of Complementary and Integrative Medicine focuses on evidence concerning the efficacy and safety of complementary and alternative medical (CAM) whole systems, practices, interventions and natural health products, including herbal medicines.

Search